Evidence map›Paper›PMID 22424423›Full record

ArticleGenome biology2012

MAnorm: a robust model for quantitative comparison of ChIP-Seq data sets.

Zhen Shao, Yijing Zhang, Guo-Cheng Yuan, Stuart H Orkin, David J Waxman

Abstract read
In one paragraph

Article in Genome biology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 281 papers.

0numbers the graph read from it
0cells of the map it votes in
281citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

281 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. RNA-binding proteins connect Exon usage to the chromatin.NAR genomics and bioinformatics · 2025
    Article

221 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Zhen ShaoDepartment of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA 02115, USA.
Yijing Zhang
Guo-Cheng Yuan
Stuart H Orkin
David J Waxman

Funding

Regulation of Sex Differences in Liver MetabolismR01DK033765 · NIDDK · DANA-FARBER CANCER INSTITUTE · PI WAXMAN, DAVID J · 1986 to 2017
$8.7M
Toward a systematic understanding of targeting mechanisms for epigenetic factorsR01HG005085 · NHGRI · DANA-FARBER CANCER INST · PI YUAN, GUO-CHENG · 2011 to 2014
$1.7M
NHGRI NIH HHS R01 HG005085NIDDK NIH HHS R01 DK033765
6 · The paper itself

Abstract

ChIP-Seq is widely used to characterize genome-wide binding patterns of transcription factors and other chromatin-associated proteins. Although comparison of ChIP-Seq data sets is critical for understanding cell type-dependent and cell state-specific binding, and thus the study of cell-specific gene regulation, few quantitative approaches have been developed. Here, we present a simple and effective method, MAnorm, for quantitative comparison of ChIP-Seq data sets describing transcription factor binding sites and epigenetic modifications. The quantitative binding differences inferred by MAnorm showed strong correlation with both the changes in expression of target genes and the binding of cell type-specific regulators.

Indexed as

Genome, HumanModels, GeneticAlgorithmsBinding SitesChromatinChromatin ImmunoprecipitationEmbryonic Stem CellsEpigenesis, GeneticGene Expression ProfilingGenome-Wide Association StudyGenomicsHeLa CellsHistonesHumansK562 CellsOrgan SpecificityChromatinHistonesTranscription Factors

Identifiers

PMID22424423
PMCPMC3439967

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.